Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice
暂无分享,去创建一个
C. Bernstein | J. Andrews | G. Moran | F. Rieder | K. Katsanos | J. Cheon | S. Ben-Horin | X. Roblin | O. Har-Noy | G. Roda | C. Stone | Min-Hu Chen | K. Karmiris | D. Schwartz | F. Steinwurz | Marijana Protic | M. Cesarini | M. Protic
[1] James A. Proudfoot,et al. No Benefit of Concomitant 5‐Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials , 2018, The American Journal of Gastroenterology.
[2] C. Paterson,et al. Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission , 2015, Digestive Diseases and Sciences.
[3] R. Russell,et al. Management of Crohn's disease. , 2016, Archives of disease in childhood.
[4] T. Imperiale,et al. Stool Testing for Colorectal Cancer Screening. , 2015, Gastroenterology.
[5] J. Wehkamp,et al. Management of Crohn’s disease – are guidelines transferred to clinical practice? , 2015, United European gastroenterology journal.
[6] E. Cabré,et al. Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids. , 2014, Journal of Crohn's & colitis.
[7] Y. Jung,et al. Clinical outcomes and predictive factors in oral corticosteroid-refractory active ulcerative colitis. , 2013, World journal of gastroenterology.
[8] S. Vermeire,et al. Second European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Current management , 2012 .
[9] K. Farkas,et al. Response to first intravenous steroid therapy determines the subsequent risk of colectomy in ulcerative colitis patients. , 2011, Journal of gastrointestinal and liver diseases : JGLD.
[10] P. Moayyedi,et al. Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: Antibiotics alone or combined antibiotics/immunomodulators? , 2011, Inflammatory bowel diseases.
[11] Stefan Zeuzem,et al. Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B. , 2009, Journal of hepatology.
[12] S. Targan,et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. , 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[13] Paul Rutgeerts,et al. Infliximab for induction and maintenance therapy for ulcerative colitis. , 2005, The New England journal of medicine.
[14] S. Truelove,et al. Cortisone in ulcerative colitis; final report on a therapeutic trial. , 1955, British medical journal.
[15] S. Truelove,et al. Cortisone in Ulcerative Colitis , 1954 .